Companies /Healthcare
Cencora Inc
NYSE: COR Medical Distribution
$321.35
▲ $4.10 (+1.29%) today
Markets closed · 10:07pm ET

Cencora (COR) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
83%
EPS beat rate
+3.01%
Avg. EPS surprise
Consecutive EPS beats
COR vs Market · 30-day return after each reportCORS&P 500
−5%0%+5%+10%−6.8%+6.9%Q2 25+5.0%+2.5%Q3 25−4.6%+0.9%Q4 25+9.7%−1.2%Q1 26+8.4%+0.7%Q2 26+4.3%+0.1%Q3 26
−5%0%+5%+10%Q2 25Q4 25Q2 26
COR EPS Trend · estimate vs actualEstimateActual
$0$2$4$4.10$4.42Q2 25$3.84$4.00Q3 25$3.79$3.84Q4 25$4.04$4.08Q1 26$4.73$4.75Q2 26
$0$2$4Q2 25Q3 25Q4 25Q1 26Q2 26
COR Revenue Trend · estimate vs actualEstimateActual
$0$30.0B$60.0B$90.0B$75.8B$75.5BQ2 25$80.1B$80.7BQ3 25$83.4B$83.7BQ4 25$86.2B$85.9BQ1 26$81.0B$78.4BQ2 26
$0$30.0B$60.0B$90.0BQ2 25Q3 25Q4 25Q1 26Q2 26

How Often Does Cencora Beat Earnings Estimates?

Cencora beat EPS estimates in 5 of its last 6 reported quarters, and has beaten 5 quarters in a row.

COR quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 $4.48 — $84.8B —
Q2 2026 $4.75 est. $4.73 +0.48% $78.4B est. $81.0B −3.31%
Q1 2026 $4.08 est. $4.04 +0.99% $85.9B est. $86.2B −0.28%
Q4 2025 $3.84 est. $3.79 +1.44% $83.7B est. $83.4B +0.40%
Q3 2025 $4.00 est. $3.84 +4.23% $80.7B est. $80.1B +0.68%
Q2 2025 $4.42 est. $4.10 +7.92% $75.5B est. $75.8B −0.46%

Figures from SEC filings and company reports. Not investment advice.